
Journal of Medicinal Chemistry p. 6972 - 6984 (2019)
Update date:2022-08-02
Topics:
Hobbs, Heather
Bravi, Gianpaolo
Campbell, Ian
Convery, Maire
Davies, Hannah
Inglis, Graham
Pal, Sandeep
Peace, Simon
Redmond, Joanna
Summers, Declan
4-(Pyrimidin-4-yl)morpholines are privileged pharmacophores for PI3K and PIKKs inhibition by virtue of the morpholine oxygen, both forming the key hydrogen bonding interaction and conveying selectivity over the broader kinome. Key to the morpholine utility as a kinase hinge binder is its ability to adopt a coplanar conformation with an adjacent aromatic core favored by the morpholine nitrogen nonbonding pair of electrons interacting with the electron deficient pyrimidine Π-system. Few selective morpholine replacements have been identified to date. Herein we describe the discovery of a potent non-nitrogen containing morpholine isostere with the ability to mimic this conformation and its application in a potent selective dual inhibitor of mTORC1 and mTORC2 (29b).
View MoreJinhua City Mingzhu Pharmaceutical Co.,Ltd.
Contact:15857995878 0579-82207761
Address:No.169 Shenze Road, New Area,Jinpan Development Zone, Jinhua
SHUNYUANSHENG BIO-PHARMTECH CO., LTD
website:https://www.whsysbio.com
Contact:--
Address:Building 13, Liandong U Valley-Wuhan Economic Innovation Valley, No. 259, Xingsan Road, Shamao Street, Hannan District, Wuhan City, Hubei Province
LinHai Cina Chemical Co., LTD.
Contact:0576-85580989
Address:Pharma-chem zone,Duqiao,Linhai,Zhejiang,China
Contact:18669908765
Address:Zibo City, Shandong Province, P.R.China
Jiangsu Allyrise Pharmaceutical Co., Ltd.(expird)
Contact:+86-523-86818997
Address:Taizhou,Jiangsu Province,CHINA
Doi:10.1016/0008-6215(92)80081-B
(1992)Doi:10.1021/ol2021687
(2011)Doi:10.1111/j.2042-7158.1991.tb05442.x
(1991)Doi:10.1080/00397919108055454
(1991)Doi:10.1021/jo00071a019
(1993)Doi:10.1080/10426507.2010.532840
(2011)